Published in Urology on July 01, 1985
Assessment of antibiotic prophylaxis prescribing patterns for TURP: A need for Canadian guidelines? Can Urol Assoc J (2013) 1.70
Bioavailability of ampicillin and amoxicillin in fasted and nonfasted subjects. J Pharm Sci (1977) 1.85
Current-voltage curve of sodium channels and concentration dependence of sodium permeability in frog skin. J Physiol (1977) 1.83
Radical prostatectomy versus expectant treatment for early carcinoma of the prostate. Twenty-three year follow-up of a prospective randomized study. Scand J Urol Nephrol Suppl (1995) 1.83
Urodynamic and histological correlates of benign prostatic hyperplasia. J Urol (1988) 1.59
Rosamicin--a new drug for the treatment of bacterial prostatitis. Antimicrob Agents Chemother (1977) 1.37
Radical prostatectomy versus expectant primary treatment in stages I and II prostatic cancer. A fifteen-year follow-up. Urology (1990) 1.32
Ciprofloxacin pharmacokinetics in patients with normal and impaired renal function. Antimicrob Agents Chemother (1987) 1.25
Netilmicin pharmacokinetics after single intravenous doses to elderly male patients. Antimicrob Agents Chemother (1977) 1.23
Urinary tract infections following transurethral prostatectomy: with special reference to the use of antimicrobials. J Urol (1970) 1.18
The importance of the pressure in the prostatic fossa and absorption of irrigating fluid during transurethral resection of the prostate. J Urol (1973) 1.16
3-year followup of urinary symptoms after transurethral resection of the prostate. J Urol (1986) 1.15
Rosamicin in urethral and vaginal secretions and tissues in dogs and rats. Antimicrob Agents Chemother (1977) 1.15
Mezlocillin pharmacokinetics after single intravenous doses to patients with varying degrees of renal function. Antimicrob Agents Chemother (1980) 1.15
Experimental models for determination of antimicrobials in prostatic tissue, interstitial fluid and secretion. Scand J Infect Dis Suppl (1978) 1.14
Pharmacokinetics of cefamandole in patients with normal and impaired renal function. Antimicrob Agents Chemother (1977) 1.11
Analysis of presenting symptoms in prostatism. J Urol (1984) 1.09
Oxolinic acid, a new chemotherapeutic agent in the treatment of urinary tract infection. J Urol (1971) 1.08
Pharmacokinetics of piperacillin in subjects with various degrees of renal function. Antimicrob Agents Chemother (1983) 1.08
Rosoxacin and cinoxacin distribution in prostate, vagina, and female urethra. An experimental study in dogs. Invest Urol (1979) 1.07
Influence of probenecid on serum levels and urinary excretion of cinoxacin. Antimicrob Agents Chemother (1979) 1.06
Scrotal herniation of the lower urinary tract. J Urol (1967) 1.05
Route and prophylaxis of ascending bladder infection in male patients with indwelling catheters. J Urol (1972) 1.03
Chloride channels in toad skin. Philos Trans R Soc Lond B Biol Sci (1982) 1.02
Isolation and biological activity of aspidospermine and quebrachamine from an Aspidosperma tree source. J Pharm Biomed Anal (1994) 1.01
Gentamicin and gentamicin C1 in the treatment of complicated urinary tract infections: comparative study of efficacy, tolerance, and pharmacokinetics. Antimicrob Agents Chemother (1975) 1.01
Pharmacokinetics of the aminoglycoside antibiotic tobramycin in humans. Antimicrob Agents Chemother (1973) 1.01
Treatment of urinary tract infections with cefotaxime: noncomparative and prospective comparative trials. Rev Infect Dis (1983) 1.00
Sodium recirculation and isotonic transport in toad small intestine. J Membr Biol (1999) 0.99
Prostatic tissue and fluid concentrations of trimethoprim and sulfamethoxazole: experimental and clinical studies. Urology (1976) 0.99
High-pressure liquid chromatographic assay of sulbactam in plasma, urine, and tissue. Antimicrob Agents Chemother (1986) 0.98
Intravenous administration of sodium colistimethate in urinary tract infections. Curr Ther Res Clin Exp (1967) 0.98
Antimicrobial prophylaxis in urologic surgery. Urol Clin North Am (1986) 0.97
Comparison of netilmicin and amikacin in treatment of complicated urinary tract infections. Antimicrob Agents Chemother (1978) 0.97
Significance of prostatic weight in prostatism. Urol Int (1983) 0.96
Pathways for chloride and sodium transport across toad skin. Acta Physiol Scand (1976) 0.95
ANO1 (TMEM16A) in pancreatic ductal adenocarcinoma (PDAC). Pflugers Arch (2014) 0.94
Bioavailability and speciation of arsenic in carrots grown in contaminated soil. Analyst (1998) 0.93
Bacterial prostatitis: new methods of treatment. Urology (1991) 0.92
Experimental lipid A-induced nephritis in the dog. Invest Urol (1975) 0.92
Ion secretion and isotonic transport in frog skin glands. J Membr Biol (1996) 0.92
Urological situation five years after spinal cord injury. Scand J Urol Nephrol (1999) 0.92
Cefamandole and cefazolin in the therapy of complicated urinary tract infections. J Infect Dis (1978) 0.91
Membrane potentials and intracellular Cl- activity of toad skin epithelium in relation to activation and deactivation of the transepithelial Cl- conductance. J Membr Biol (1986) 0.91
Comparison of ion transport by cultured secretory and absorptive canine airway epithelia. Am J Physiol (1988) 0.91
Morphology of the kidney in larvae of Bufo viridis (Amphibia, Anura, Bufonidae). J Morphol (2000) 0.91
Chloride transport in toad skin (Bufo viridis). The effect of salt adaptation. J Exp Biol (1984) 0.90
Posttraumatic priapism: successful treatment with autologous clot embolization. AJR Am J Roentgenol (1979) 0.90
The relevance of minimum urethral resistance in prostatism. J Urol (1983) 0.89
Pharmacokinetics of cefuroxime in normal and impaired renal function: comparison of high-pressure liquid chromatography and microbiological assays. Antimicrob Agents Chemother (1981) 0.89
Effect of urine concentration versus tissue concentration of ampicillin and mecillinam on bacterial adherence in the rat bladder. Invest Urol (1981) 0.89
Symptom analysis and uroflowmetry 7 years after transurethral resection of the prostate. J Urol (1989) 0.89
Treatment of benign prostatic hypertrophy with progestational agents: a preliminary report. J Urol (1968) 0.89
Regulation of prostatic smooth muscle contractility by intracellular second messengers: implications for the conservative treatment of benign prostatic hyperplasia. Urol Int (1995) 0.89
MICs of ciprofloxacin and trimethoprim for Escherichia coli: influence of pH, inoculum size and various body fluids. Infection (1991) 0.89
Malignant interstitial cell testicular tumor. Cancer (1973) 0.89
Intracavernous self-injection with phentolamine and papaverine for the treatment of impotence. J Urol (1987) 0.88
Iodine content in drinking water and other beverages in Denmark. Eur J Clin Nutr (2000) 0.87
Fibrosis of corpus cavernosum after intracavernous injection of phentolamine/papaverine. J Urol (1987) 0.87
Prophylactic antibiotics in transurethral prostatectomy. J Urol (1981) 0.87
Sisomicin treatment of complicated urinary tract infections: efficacy, tolerance and pharmacokinetics. J Clin Pharmacol (1974) 0.87
Determination of absorption of irrigating fluid during transurethral resection of the prostate by means of radioisotopes. J Urol (1969) 0.87
Value of postvoid residual urine determination in evaluation of prostatism. Urology (1982) 0.86
Maxi K+ channels co-localised with CFTR in the apical membrane of an exocrine gland acinus: possible involvement in secretion. Pflugers Arch (2001) 0.86
Aztreonam concentrations in human prostatic tissue. Antimicrob Agents Chemother (1984) 0.86
Transurethral resection versus incision of the prostate: a randomized, prospective study. Urology (1995) 0.86
Secretion of various antimicrobial substances in dogs with experimental bacterial prostatitis. Urol Res (1977) 0.85
Spontaneous uroflowmetry in prostatism. Urology (1984) 0.85
Transurethral prostatic resection in the treatment of prostatism with high urinary flow. J Urol (1983) 0.85
Migration of nanosized layered double hydroxide platelets from polylactide nanocomposite films. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2011) 0.85
Anoctamin 6 differs from VRAC and VSOAC but is involved in apoptosis and supports volume regulation in the presence of Ca2+. Pflugers Arch (2014) 0.85
Combining asymmetrical flow field-flow fractionation with light-scattering and inductively coupled plasma mass spectrometric detection for characterization of nanoclay used in biopolymer nanocomposites. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2009) 0.84
Survival of invasive bladder cancer patients, 1998-2009; a central and northern Denmark population-based cohort study. Clin Epidemiol (2011) 0.84
Ammonium bicarbonate as a replacement for carbon dioxide in Transgrow bottles for primary isolation of Neisseria gonorrhoeae. J Clin Microbiol (1983) 0.84
The significance of uninhibited detrusor contractions in prostatism. J Urol (1985) 0.84
Transurethral resection versus transurethral incision of the prostate. A prospective randomized study. Urol Clin North Am (1990) 0.83
Intake of household salt in a Danish population. Eur J Clin Nutr (2008) 0.83
Chronic bacterial prostatitis: theoretical and experimental considerations. Urol Res (1983) 0.83
Efficacy and pharmacokinetics of tobramycin in patients with chronic urinary tract infections and various degrees of renal impairment. Infection (1974) 0.83
Scanning electron microscopy of normal and malignant human urothelium. Urology (1976) 0.83
Renal lymph and interstitial fluid concentration of co-trimazine: an experimental study in dogs. Infection (1979) 0.83
Ceftazidime, a new cephalosporin in the treatment of complicated urinary tract infections: a comparative study with tobramycin. J Urol (1983) 0.82
Antibiotics excretion in canine vaginal and urethral secretions. Invest Urol (1978) 0.82
Comparison of iodinated contrast media-induced renal vasoconstriction in human, rabbit, dog, and pig arteries. Invest Radiol (1997) 0.82
Fleroxacin (Ro 23-6240) distribution in canine prostatic tissue and fluids. Antimicrob Agents Chemother (1987) 0.82
Pharmacokinetics of ampicillin and methoxymethyl ester of hetacillin in dogs. J Pharm Sci (1977) 0.82
Short-term cephalosporin prophylaxis in transurethral surgery. Clin Ther (1982) 0.81
Results and complications of tension-free vaginal tape (TVT) for surgical treatment of female stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2001) 0.81
Prostatic fluid and tissue concentrations of ampicillin after administration of hetacillin ester (BL-P1761). Invest Urol (1976) 0.81
Role of intracellular Ca2+ stores in smooth muscle contractions of the guinea pig vas deferens. Urol Res (1993) 0.81
Comparison of concentrations of rifampin and a new rifamycin derivative, DL 473, in canine bone. Antimicrob Agents Chemother (1983) 0.81
Treatment of complicated urinary tract infections. Comparative study of sisomicin and gentamicin. Urology (1977) 0.81
Proton pump activity of mitochondria-rich cells. The interpretation of external proton-concentration gradients. J Gen Physiol (1997) 0.81
Validation of methods for the detection and quantification of engineered nanoparticles in food. Food Chem (2012) 0.81
Treatment of urinary tract infections with cephalexin. J Urol (1971) 0.80